Publications by authors named "F Veber"

Claim this Profile
B
Bictegravir/emtricitabine/tenofovir alafenamide in paediatrics: Real-life experience from a French cohort (2019-2023).
P Frange, F Veber, M Burgard, S Blanche, V Avettand-Fenoel

HIV Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No overall impact on body mass index for age change after dolutegravir initiation in a French paediatric cohort.
Pierre Frange, Veronique Avettand-Fenoel, Florence Veber, Stephane Blanche

HIV Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dolutegravir in the long term in children and adolescents: frequent virological failure but rare acquired genotypic resistance.
Pierre Frange, Stephane Blanche, Florence Veber, Veronique Avettand-Fenoel

HIV Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Early Versus Late Antiretroviral Treatment Initiation on Naive T Lymphocytes in HIV-1-Infected Children and Adolescents - The-ANRS-EP59-CLEAC Study.
Pierre Frange, Thomas Montange, Jérôme Le Chenadec, Damien Batalie, Ingrid Fert, Florence Veber

Front Immunol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High rates of antiretroviral coverage and virological suppression in HIV-1-infected children and adolescents.
A Soumah, V Avettand-Fenoel, F Veber, D Moshous, N Mahlaoui

Med Mal Infect· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis